Robot Assisted Radical Cystectomy with Intracorporeal Ileal Conduit (RARC + IC)

Robot Assisted Radical Cystectomy with Intracorporeal Ileal Conduit (RARC + IC) is a sophisticated surgical technique used to treat advanced bladder cancer. This procedure involves the removal of the bladder, followed by the creation of an ileal conduit, which is an alternative urinary diversion method. Robotic assistance allows for increased precision in performing the radical cystectomy, reducing the invasiveness of the procedure with smaller incisions and enhanced visualization. The use of robotic technology ensures that the surgeon can carefully remove the bladder and surrounding tissues with minimal trauma to adjacent structures. After the bladder is removed, a segment of the patient’s small intestine (ileum) is used to create a conduit that diverts urine from the kidneys to an external ostomy bag. This approach is often chosen when a patient is not a candidate for an intracorporeal neo-bladder or when a more straightforward diversion is preferred.

Post-Surgery Recovery and Benefits of RARC + IC

The benefits of RARC + IC are numerous, particularly in terms of recovery and quality of life after surgery. The minimally invasive nature of robotic surgery generally results in less pain, fewer complications, and shorter hospital stays compared to traditional open surgery. Most patients are able to return home within a few days and gradually resume their normal activities within a few weeks. The ileal conduit, although requiring an external ostomy bag for urine collection, is a well-established and reliable method of urinary diversion, offering patients a functional and manageable solution. While the recovery process involves adjustments to the use of the ostomy bag, patients often experience greater comfort and less disruption to daily life due to the precision of the robotic-assisted procedure. Despite the challenges of managing a urinary diversion, RARC + IC provides an effective and safer surgical option for bladder cancer patients, allowing them to achieve long-term cancer control while maintaining an improved quality of life.

120K +

HAPPY PATIENTS

200

SPECIALIST DOCTORS

30+

MEDICAL SERVICES

150K

PROBLEM SOLVE